Simplified nasal provocation test can remove side effects of specific local nasal immunotherapy

Rivista Italiana di Otorinolaringologia Audiologia e Foniatria

Volumn 16, Issue 1, 1996, Pages 21-25

  Bellussi, L ^a   Dentici, R ^b   Di Berardino, L ^a   Fregoso, A ^b   Passali D ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Ospedale di Bollate   (Italy)

Author keywords

Allergic rhinitis; Intranasal specific immunotherapy; Specific nasal provocation test

Indexed keywords

EID: 0009068764     PISSN: 03921360     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ANDRI L., SENNA G.E., BETTELI, GIVANNI S., ANDRI G., FALAGIANI P., LUGO G.: Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy, 47: 318, 1992.
2. ANDRI L., SENNA G.E., BETTELI, GIVANNI S., ANDRI G., FALAGIANI P., LUGO G.: Local nasal immunotherapy (LNIT) with extract in powder form for allergic Dermatophagoides rhinitis. Annals of Allergy, 68: 86, 1992.
3. ANGRISANO A., PISSACROIA C., UBOLDI F., DI BERARDINO L.: Local nasal immunotherapy in the treatment of Grass allergies and the efficacy of a simplified low-dosage plan in children with oculorhinitis. Allergy, Suppl. 26, 50: 58, 1995.
4. BJÖRKSTÉN B.: Local immunotherapy is not documented for clinical use. Allergy, 49: 229, 1994.
5. DEUSCHL H., JOHANSON S.G.O.: Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study. Acta Allergol.,32: 248, 1977.
6. DEUSCHL H., WELSH P.W., ZIMMERMANN E.M., YUNGINGER J.W., KERN E.B., GLEICH G.J.: Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J. Allergy Clin. Immunol., 67: 237, 1981.
7. GEORGITIS J.W., REISMAN R.E., CLAYTON W.F., MUELLER U.R., WYPYCH J.I., ARBESMANN C.E.: Local intranasal immunotherapy for grass-allergic rhinitis. J. Allergy Clin. Immunol., 71: 71, 1983.
8. GEORGITIS J.W., NICKELSEN J.A., WYPYCH J.L., BARDE S.H., CLAYTON W.F., REISMAN R.E.: Local intranasal immunotherapy with high-dose polymerized ragweed extract. Int. Arch. Allergy Appl. Immunol., 3: 170, 1986.
9. JOHANSON S.G.O., DEUSCHL H., ZETTERSTROM O.: Use of Glutaraldeyde-modified Timothy grass pollen extract in nasal hyposensitization treatment of hay fever. Int. Archs Allergy. Appl. Immun., 60; 447, 1979.
10. MEHTA S.B., SMITH J.M.: Nasal hyposensitization and hay fever. Clin. Allergy, 5: 279, 1975.
11. MISTRELLO G., RAPISARDA G., FALAGIANI P.: Detection of IgE-binding activity in serum after intranasal treatment of normal rabbits with P. judaica extract. Allergy, 46: 52, 1991.
12. NICKELSEN J.A., GOLDSTEIN S., MUELLER U., WYPYCH J., REISMAN R.E., ARBESMAN C.E.: Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response. J. Allergy Clin. Immunol., 68: 33, 1981.
13. TAYLOR G., SHIVALKA R.: Changes in nasal airways resistance on antigenic challenge in allergic rhinitis. Clinical Allergy, 1: 63, 1971.
14. WELSH P.W., BUTTERSFIELD J.H., YUNGINGER J.W., AGARWAL M.K., GLEICH G.J.: Allergen-controlled study of intranasal immunotherapy for ragweed hay fever. J. Allergy Clin. Immunol., 71: 454, 1983.